Minogue 2005.
Methods | Randomized controlled trial | |
Participants | Age (years, mean ± SD): Benzyl alcohol group (BA) = 44 ± 16, Placebo group (PL) = 41 ±12, Lidocaine group (LI) = 41 ± 12 Gender (M:F): BA group = 8:31, PL group = 18:21, LI group = 7:35 Inclusion criteria: ASA I‐II, elective surgery Exclusion criteria: N/A Recruitment: 120 adult patients randomly assigned Setting: Canada |
|
Interventions |
Admixture The benzyl alcohol (BA; n = 39) group received 10 ml of bacteriostatic saline followed by 5 ml (50 mg) of propofol. The lidocaine (LI; n = 42) group, 1 ml of 2% lidocaine (20 mg) was premixed with 19 ml of propofol (190 mg). Ten ml of preservative‐free normal saline was then administered followed by 5 ml of the propofol and lidocaine mixture The placebo (PL; n = 39) group received 10 ml of preservative‐free normal saline followed by 5 ml of propofol |
|
Outcomes | Pain intensity assessed on 4‐point scale 0 = no pain 1 = mild pain 2 = moderate pain 3 = severe pain Outcomes reported and used
Outcomes sought but not reported
|
|
Notes | Period of the study: dates not reported | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Using a randomly‐generated computer assignment |
Allocation concealment (selection bias) | Unclear risk | N/A |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | "The agents were prepared by the investigator and given to the attending anaesthesiologist who was blinded as to the contents." |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | N/A |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No withdrawals |
Selective reporting (reporting bias) | Unclear risk | N/A |
Other bias | Low risk | The study appears to be free of other sources of bias |